Khan et al. [87] showed that Survivin, an inhibitor of apoptosis member, could bedetected in plasma-derived EVs from both prostate cancer patients and healthy subjects;however, the relative amount of EV Survivin was remarkably higher in the plasma ofprostate cancer patients. The gene discussed is BIRC5; the disease is prostate carcinoma.